ArticleAnalytical and bioanalytical chemistry2026
Surface-enhanced Raman scattering detection of matrix metalloproteinase-9 via an aptamer-based plasmonic ruler.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Matrix metalloproteinase-9 (MMP-9) plays a crucial role in cancer cell invasion, metastasis, and tumor growth. However, the precise and sensitive detection of MMP-9 remains a significant challenge, impeding a deeper understanding of its multifaceted roles in cancer progression. This study developed a novel surface-enhanced Raman scattering (SERS) sensing strategy based on DNA bending for ultrasensitive, highly selective detection of MMP-9. In the sensing system, MMP-9 aptamers and methylene blue-labeled complementary DNA were co-modified on a magnetic/plasmonic bead to fabricate a SERS probe. When target MMP-9 was present, the aptamer bound to the target and detached from the SERS nanoprobe, and the complementary DNA chain modified with methylene blue, due to its bending and the resultant closer proximity to the SERS nanoprobe surface, led to enhanced SERS signals. Meanwhile, cell experiments have confirmed that intensified hypoxia can directly lead to a significant increase in MMP-9 expression. Due to the high affinity between the aptamer and the target, this sensing system has high selectivity. The detection limit arrives at 3.67 ng/mL. We applied this sensor to determine MMP-9 in patient sera and obtained consistent results with the standard method. This strategy is expected to develop into a new method for diagnosing specific cancers related to MMP-9 and for evaluating the occurrence, development, and extent of cancer metastasis.
Indexed as
Identifiers
42219427What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.